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Since their introduction, coronary artery bypass grafting (CABG)
and percutaneous coronary intervention (PCI) have become the
standards of care for the large majority of patients with coronary
artery disease (CAD) and, by the way, two of the most performed
procedures in medicine, worldwide. Both therapies are ubiqui-
tously available in the western world but, interestingly, there are
large differences in the provision of PCI and CABG: ﬁrst between
different countries and, as demonstrated by Baig et al., also within
the same country with a maximal degree of variation of the ratio
PCI/CABG of more than 13-fold. The authors have to be congratu-
lated for bringing these important pieces of informations to the
readership of EJCTS and thereby for stimulating thought on how
to interpret these numbers?
In the last 20 years, numerous randomized trials comparing
PCI to CABG have shown comparable outcomes for selected
patient populations [1, 2] and provided more evidence for wider
use of PCI despite the fact that several developments (off-pump
surgery, minimized extracorporeal technology, improved myo-
cardial protection, endoscopic vein harvesting) have made CABG
less invasive and highly competitive to PCI. Unfortunately, and
because CABG is sometimes described by cardiologists as a pro-
cedure where ‘the chest is cracked open’, patients often prefer
PCI to CABG because they believe a stitch in the groin is always
better than a scar on the chest. In addition, a shorter stay in hos-
pital and the hope for a shorter rehabilitation are attractive
prospects.
The paper by the group of David Taggart present some
expected but also some unexpected items of information con-
cerning the provision of PCI and CABG in the UK [3]. It is very
interesting for several aspects: it shows that the provision of PCI
and CABG (expressed at least partially by the ratio of PCI to CABG)
may be extremely different, even in the same country. In addition,
the authors have shown that these differences were not patient
related and cannot be explained by the volume of interventions
performed. The large differences in the treatment of CAD in the
UK call for additional hypotheses:
(i) the geographical location of the cardiology and cardiac
surgery units;
(ii) the organization of the cardiology unit (run alone or with a
cardiac surgery unit);
(iii) the presence or not of a heart team on the site;
(iv) and ﬁnally from the knowledge and education of general
practitioners and patients.
For judicious decision-making in every single patient, it is essen-
tial to consider the risk/beneﬁt ratios of both procedures; this
means careful evaluation of procedural invasiveness and the
associated short-term complications against the probability of an
adverse long-term event (death, myocardial infarction, repeat
revascularization and absence of improvement in quality of life).
The lecture of this paper leads to some comments: some are
directly related to the observations described in this paper, while
others are general statements on how patients with signiﬁcant
CAD are dealt with today in a majority of institutions:
(i) First of all, both the European Society of Cardiology and the
European Association for Cardio-Thoracic Surgery have
published Guidelines for the treatment of CAD [4]. While the
indications have been described in detail for every type of
coronary vessel involvement, it is surprising to assert that a
substantial proportion of patients are treated by PCI outside
of evidence-based indications [5].
(ii) In several situations, it appears that the patients decide—on
the basis of a biased piece of information through cardiolo-
gists—which type of treatment should be performed. Do
the patients have enough knowledge for this? Certainly not.
Let us just imagine a similar decision-making situation in
oncology: the patient would choose the option with the
less durable results, just because it is less invasive (or it
causes less side-effects) but is followed by a higher rate of
recurrences!
(iii) It is a clear fact that the information given to the patients in
the cath lab disproportionally emphasizes short-term results
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even though CABG has been shown to be superior to PCI
with respect to long-term survival and angina relief, at least
in the presence of left main stenosis and three-vessel
disease.
(iv) There have been extended discussions about the necessity
and the value of ‘heart teams’ in the recent literature, not
only following the results of the SYNTAX study but also to
implement robust TAVI programmes. Unfortunately, the
heart team approach is usually considered as a ‘nice to have’
option and not as an effective discussion tool to exchange
scientiﬁc arguments between cardiologists and cardiac sur-
geons. As a result of this, for instance, the SYNTAX score,
which was warmly recommended in the publications, is not
used routinely in a majority of institutions.
(v) The value of ‘ad hoc’ PCI should be questioned. Although it
is desirable to improve the efﬁciency within the organization
(saving money and reducing delay until deﬁnitive treat-
ment), it is not the best solution for all patients. Ad hoc PCI
does not allow in-depth discussion with colleagues and
patients. In addition, this approach does not allow an alter-
native treatment (CABG) to be presented to the patient the
cardiologist informs the patient about CABG surgery (!!!).
This is medically not justiﬁable and ethically questionable.
(vi) In the last decade, there has been an explosion of cardi-
ology units that are able to offer PCI without the need
nor the possibility to properly discuss the pros and cons
but sometimes in those patients in whom CABG would
lead to superior results. Moreover, when problems happen
during the short- or mid-term follow-up, the control
examinations are usually performed by the same team that
provided the initial PCI. This precludes a critical appraisal
and control of the results obtained by PCI.
(vii) Finally, a word of caution is needed: cardiologists are not
always responsible for this development. Hospital managers
nowadays deal increasingly (when not exclusively) with
ﬁnancial incentives when the budgets of their units are
concerned. Therefore, health-care providers (in this case
cardiologists) have only the possibility of increasing the
number of PCIs (in the worst scenario with marginal or
even inappropriate indication) to fulﬁl the budget numbers
and satisfy their managers. These incentives are not only
perverse but also expensive for the overall healthcare
system. A discussion in depth is urgently needed to ﬁx these
problems.
The SYNTAX trial has been a signiﬁcant work to establish the
optimal revascularization strategies for patients suffering from
CAD with left main stenosis disease and three-vessel disease.
Signiﬁcant differences were found following CABG and PCI
between patients with left main stenosis and three-vessel disease.
Since this trial has provided strong evidence that CABG is superior
to PCI in reducing long-term adverse clinical end-points like
death and myocardial infarction, one can hope that the results
described in the paper of Braig et al. belong to the past.
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